Read + Share
Amedeo Smart
Independent Medical Education
O'Rourke K. Cemiplimab shines for recurrent cervical cancer. Cancer 2022;128:2050-2051.PMID: 35532190
Email
LinkedIn
Facebook
Twitter
Privacy Policy
